COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers
Ramirez PT (1), Chiva L (2), Eriksson AGZ (3), Frumovitz M (4), Fagotti A (5), Gonzalez Martin A (6), Jhingran A (7), Pareja R (8,9).
(1)Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
(2) Obstetrics and Gynecology, Clinica Universidad de Navarra, MADRID, Spain.
(3) Department of Gynecologic Oncology, Division of Cancer Medicine, The Norwegian Radium Hospital; Oslo University Hospital, Oslo, Norway.
(4) Gynecologic Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
(5) Woman and Child's Health Department, Universita Cattolica del Sacro Cuore Facolta di Medicina e Chirurgia, Roma, Roma, Italy.
(6) Medical Oncology, Clinica Universidad de Navarra, Madrid, Madrid, Spain.
(7) Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
(8) Gynecologic Oncology, Clinica ASTORGA, Medellin, Colombia.
(9) Instituto Nacional de Cancerología, Bogotá, Colombia.
Our world is facing a devastating crisis in the growing pandemic associated with the coronavirus (COVID-19) disease.
As many nations take steps to implement strategies to contain the spread of this disease, we continue to see the tremendous impact this is having on the numerous healthcare workers who unite to overcome this tragic infection. We also recognize the concerns by both physicians and patients as it pertains to the management of patients diagnosed with cancer.
We recognize that in this special situation we must continue to provide our gynecologic oncology patients with the highest quality of medical services and at the same time assure that we maximize the safety not only of our patients and their families but also of the medical staff and all associated teams that care for patients both in the inpatient and outpatient settings.
To that end, the Editorial Team of the International Journal of Gynecological Cancer have compiled evidence-based data using established guidelines to propose strategies to optimize care of our patients while at the same time offering potential options to alleviate the burden to the healthcare system when resources may need to be diverted to the direct care of patients affected by the coronavirus (COVID-19) disease.
Our proposal is intended as a tool for consideration and certainly not as a strategy for permanent change in patterns of practice. The goal is to share options, as gathered collectively by our team, in both the management and surveillance of patients diagnosed with gynecologic cancers during this time of global crisis.
CITA DEL ARTÍCULO Int J Gynecol Cancer. 2020 Mar 27. pii: ijgc-2020-001419. doi: 10.1136/ijgc-2020-001419